These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 19863495

  • 1. Clinical trial: the effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome - a randomized, double-blind, controlled study.
    Simrén M, Ohman L, Olsson J, Svensson U, Ohlson K, Posserud I, Strid H.
    Aliment Pharmacol Ther; 2010 Jan 15; 31(2):218-27. PubMed ID: 19863495
    [Abstract] [Full Text] [Related]

  • 2. Effects of probiotic fermented milk on symptoms and intestinal flora in patients with irritable bowel syndrome: a randomized, placebo-controlled trial.
    Søndergaard B, Olsson J, Ohlson K, Svensson U, Bytzer P, Ekesbo R.
    Scand J Gastroenterol; 2011 Jun 15; 46(6):663-72. PubMed ID: 21443416
    [Abstract] [Full Text] [Related]

  • 3. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B, Mun Jung S, Hwan Choi C, Song ID, Woong Lee H, Joon Kim H, Hyuk J, Kyung Chang S, Kim K, Chung WS, Seo JG.
    J Clin Gastroenterol; 2012 Mar 15; 46(3):220-7. PubMed ID: 22157240
    [Abstract] [Full Text] [Related]

  • 4. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
    Drouault-Holowacz S, Bieuvelet S, Burckel A, Cazaubiel M, Dray X, Marteau P.
    Gastroenterol Clin Biol; 2008 Feb 15; 32(2):147-52. PubMed ID: 18387426
    [Abstract] [Full Text] [Related]

  • 5. Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial.
    Guyonnet D, Chassany O, Ducrotte P, Picard C, Mouret M, Mercier CH, Matuchansky C.
    Aliment Pharmacol Ther; 2007 Aug 01; 26(3):475-86. PubMed ID: 17635382
    [Abstract] [Full Text] [Related]

  • 6. Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome.
    Zeng J, Li YQ, Zuo XL, Zhen YB, Yang J, Liu CH.
    Aliment Pharmacol Ther; 2008 Oct 15; 28(8):994-1002. PubMed ID: 18671775
    [Abstract] [Full Text] [Related]

  • 7. Long-term treatment with probiotics in primary care patients with irritable bowel syndrome--a randomised, double-blind, placebo controlled trial.
    Begtrup LM, de Muckadell OB, Kjeldsen J, Christensen RD, Jarbøl DE.
    Scand J Gastroenterol; 2013 Oct 15; 48(10):1127-35. PubMed ID: 23957590
    [Abstract] [Full Text] [Related]

  • 8. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention.
    Kajander K, Hatakka K, Poussa T, Färkkilä M, Korpela R.
    Aliment Pharmacol Ther; 2005 Sep 01; 22(5):387-94. PubMed ID: 16128676
    [Abstract] [Full Text] [Related]

  • 9. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota.
    Kajander K, Myllyluoma E, Rajilić-Stojanović M, Kyrönpalo S, Rasmussen M, Järvenpää S, Zoetendal EG, de Vos WM, Vapaatalo H, Korpela R.
    Aliment Pharmacol Ther; 2008 Jan 01; 27(1):48-57. PubMed ID: 17919270
    [Abstract] [Full Text] [Related]

  • 10. Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome.
    Dolin BJ.
    Methods Find Exp Clin Pharmacol; 2009 Dec 01; 31(10):655-9. PubMed ID: 20140275
    [Abstract] [Full Text] [Related]

  • 11. Prescript-Assist probiotic-prebiotic treatment for irritable bowel syndrome: a methodologically oriented, 2-week, randomized, placebo-controlled, double-blind clinical study.
    Bittner AC, Croffut RM, Stranahan MC.
    Clin Ther; 2005 Jun 01; 27(6):755-61. PubMed ID: 16117982
    [Abstract] [Full Text] [Related]

  • 12. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study.
    Guglielmetti S, Mora D, Gschwender M, Popp K.
    Aliment Pharmacol Ther; 2011 May 01; 33(10):1123-32. PubMed ID: 21418261
    [Abstract] [Full Text] [Related]

  • 13. Clinical studies on alleviating the symptoms of irritable bowel syndrome.
    Kajander K, Korpela R.
    Asia Pac J Clin Nutr; 2006 May 01; 15(4):576-80. PubMed ID: 17077079
    [Abstract] [Full Text] [Related]

  • 14. Fermented milk containing Bifidobacterium lactis DN-173 010 improved self-reported digestive comfort amongst a general population of adults. A randomized, open-label, controlled, pilot study.
    Guyonnet D, Woodcock A, Stefani B, Trevisan C, Hall C.
    J Dig Dis; 2009 Feb 01; 10(1):61-70. PubMed ID: 19236549
    [Abstract] [Full Text] [Related]

  • 15. Fermented milk containing Bifidobacterium lactis DN-173 010 improves gastrointestinal well-being and digestive symptoms in women reporting minor digestive symptoms: a randomised, double-blind, parallel, controlled study.
    Guyonnet D, Schlumberger A, Mhamdi L, Jakob S, Chassany O.
    Br J Nutr; 2009 Dec 01; 102(11):1654-62. PubMed ID: 19622191
    [Abstract] [Full Text] [Related]

  • 16. A randomized, double-blind, placebo-controlled multicenter trial of saccharomyces boulardii in irritable bowel syndrome: effect on quality of life.
    Choi CH, Jo SY, Park HJ, Chang SK, Byeon JS, Myung SJ.
    J Clin Gastroenterol; 2011 Sep 01; 45(8):679-83. PubMed ID: 21301358
    [Abstract] [Full Text] [Related]

  • 17. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome.
    Nobaek S, Johansson ML, Molin G, Ahrné S, Jeppsson B.
    Am J Gastroenterol; 2000 May 01; 95(5):1231-8. PubMed ID: 10811333
    [Abstract] [Full Text] [Related]

  • 18. Probiotic lactobacilli and bifidobacteria in a fermented milk product with added fruit preparation reduce antibiotic associated diarrhea and Helicobacter pylori activity.
    de Vrese M, Kristen H, Rautenberg P, Laue C, Schrezenmeir J.
    J Dairy Res; 2011 Nov 01; 78(4):396-403. PubMed ID: 21871144
    [Abstract] [Full Text] [Related]

  • 19. Effects of synbiotic fermented milk containing Lactobacillus acidophilus La-5 and Bifidobacterium animalis ssp. lactis BB-12 on the fecal microbiota of adults with irritable bowel syndrome: A randomized double-blind, placebo-controlled trial.
    Bogovič Matijašić B, Obermajer T, Lipoglavšek L, Sernel T, Locatelli I, Kos M, Šmid A, Rogelj I.
    J Dairy Sci; 2016 Jul 01; 99(7):5008-5021. PubMed ID: 27157575
    [Abstract] [Full Text] [Related]

  • 20. Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study.
    Williams EA, Stimpson J, Wang D, Plummer S, Garaiova I, Barker ME, Corfe BM.
    Aliment Pharmacol Ther; 2009 Jan 01; 29(1):97-103. PubMed ID: 18785988
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.